OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia
Atsushi Tanaka, Taizo A. Nakano, Masaki Nomura, et al.
Blood (2022) Vol. 140, Iss. 8, pp. 875-888
Open Access | Times Cited: 15
Atsushi Tanaka, Taizo A. Nakano, Masaki Nomura, et al.
Blood (2022) Vol. 140, Iss. 8, pp. 875-888
Open Access | Times Cited: 15
Showing 15 citing articles:
SF3B1 mutations in myelodysplastic syndromes: A potential therapeutic target for modulating the entire disease process
Moqin Jiang, Meng Chen, Qian Liu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 15
Moqin Jiang, Meng Chen, Qian Liu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 15
Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemia
Katherine Knorr, Jahan Rahman, Caroline Erickson, et al.
Nature Cancer (2023) Vol. 4, Iss. 12, pp. 1675-1692
Open Access | Times Cited: 12
Katherine Knorr, Jahan Rahman, Caroline Erickson, et al.
Nature Cancer (2023) Vol. 4, Iss. 12, pp. 1675-1692
Open Access | Times Cited: 12
The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts
In Young Choi, Jonathan P. Ling, Jian Zhang, et al.
Blood Advances (2024) Vol. 8, Iss. 15, pp. 3961-3971
Open Access | Times Cited: 3
In Young Choi, Jonathan P. Ling, Jian Zhang, et al.
Blood Advances (2024) Vol. 8, Iss. 15, pp. 3961-3971
Open Access | Times Cited: 3
MECOM: a Bioinformatics and Experimentally Identified Marker for the Diagnosis and Prognosis of Lung Adenocarcinoma
Anqi Li, Meng Li, Jing Wang, et al.
Biomarkers in Medicine (2024) Vol. 18, Iss. 2, pp. 79-91
Closed Access | Times Cited: 2
Anqi Li, Meng Li, Jing Wang, et al.
Biomarkers in Medicine (2024) Vol. 18, Iss. 2, pp. 79-91
Closed Access | Times Cited: 2
SETBP1 is dispensable for normal and malignant hematopoiesis
Atsushi Tanaka, Koutarou Nishimura, Wataru Saika, et al.
Leukemia (2023) Vol. 37, Iss. 9, pp. 1802-1811
Open Access | Times Cited: 4
Atsushi Tanaka, Koutarou Nishimura, Wataru Saika, et al.
Leukemia (2023) Vol. 37, Iss. 9, pp. 1802-1811
Open Access | Times Cited: 4
EVI1-mediated Programming of Normal and Malignant Hematopoiesis
Susanne Lux, Michael D. Milsom
HemaSphere (2023) Vol. 7, Iss. 10, pp. e959-e959
Open Access | Times Cited: 4
Susanne Lux, Michael D. Milsom
HemaSphere (2023) Vol. 7, Iss. 10, pp. e959-e959
Open Access | Times Cited: 4
Analysis of 3760 hematologic malignancies reveals rare transcriptomic aberrations of driver genes
Xueqi Cao, Sandra Huber, Ata Jadid Ahari, et al.
Genome Medicine (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Xueqi Cao, Sandra Huber, Ata Jadid Ahari, et al.
Genome Medicine (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Acute myeloid leukemia (AML) with chromosome 3 inversion: biology, management, and clinical outcome
Abdulrahman Alhajahjeh, Jan Philipp Bewersdorf, Rebecca P. Bystrom, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024) Vol. 65, Iss. 11, pp. 1541-1551
Closed Access | Times Cited: 1
Abdulrahman Alhajahjeh, Jan Philipp Bewersdorf, Rebecca P. Bystrom, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024) Vol. 65, Iss. 11, pp. 1541-1551
Closed Access | Times Cited: 1
Identifying prognostic gene panels in acute myeloid leukemia
Joaquín Sánchez‐Garcia, Josefina Serrano, Esther Prados de la Torre, et al.
Expert Review of Hematology (2023) Vol. 16, Iss. 4, pp. 277-287
Closed Access | Times Cited: 2
Joaquín Sánchez‐Garcia, Josefina Serrano, Esther Prados de la Torre, et al.
Expert Review of Hematology (2023) Vol. 16, Iss. 4, pp. 277-287
Closed Access | Times Cited: 2
Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression
Christine Birdwell, Warren Fiskus, Tapan M. Kadia, et al.
Leukemia (2023) Vol. 38, Iss. 3, pp. 545-556
Closed Access | Times Cited: 2
Christine Birdwell, Warren Fiskus, Tapan M. Kadia, et al.
Leukemia (2023) Vol. 38, Iss. 3, pp. 545-556
Closed Access | Times Cited: 2
The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts
In Young Choi, Jonathan P. Ling, Jian Zhang, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
In Young Choi, Jonathan P. Ling, Jian Zhang, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Mutant SF3B1 splices a more leukemogenic EVI1
Esther A. Obeng
Blood (2022) Vol. 140, Iss. 8, pp. 800-801
Open Access | Times Cited: 2
Esther A. Obeng
Blood (2022) Vol. 140, Iss. 8, pp. 800-801
Open Access | Times Cited: 2
ERGonomics for EVI1 acute myeloid leukemia
Cécile K. Lopez, Thomas Mercher
Blood (2023) Vol. 141, Iss. 5, pp. 441-443
Open Access
Cécile K. Lopez, Thomas Mercher
Blood (2023) Vol. 141, Iss. 5, pp. 441-443
Open Access
Analysis of 3,760 hematologic malignancies reveals rare transcriptomic aberrations of driver genes
Xueqi Cao, Sandra Huber, Ata Jadid Ahari, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Xueqi Cao, Sandra Huber, Ata Jadid Ahari, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
<i>EVI1</i> Disruption Post Neuroblastoma Treatment: A Case Analysis of Treatment-Associated Acute Myeloid Leukemia in a Pediatric Patient
Xin Zhang
Case Reports in Oncology (2023) Vol. 16, Iss. 1, pp. 893-899
Open Access
Xin Zhang
Case Reports in Oncology (2023) Vol. 16, Iss. 1, pp. 893-899
Open Access
